Appella E - Search Results

1

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.

Mayordomo JI, Loftus DJ, Sakamoto H, De Cesare CM, Appasamy PM, Lotze MT, Storkus WJ, Appella E, DeLeo AB. Mayordomo JI, et al. Among authors: appella e. J Exp Med. 1996 Apr 1;183(4):1357-65. doi: 10.1084/jem.183.4.1357. J Exp Med. 1996. PMID: 8666894 Free PMC article.

2

The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope.

Hoffmann TK, Loftus DJ, Nakano K, Maeurer MJ, Chikamatsu K, Appella E, Whiteside TL, DeLeo AB. Hoffmann TK, et al. Among authors: appella e. J Immunol. 2002 Feb 1;168(3):1338-47. doi: 10.4049/jimmunol.168.3.1338. J Immunol. 2002. PMID: 11801674

3

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells.

Chikamatsu K, Nakano K, Storkus WJ, Appella E, Lotze MT, Whiteside TL, DeLeo AB. Chikamatsu K, et al. Among authors: appella e. Clin Cancer Res. 1999 Jun;5(6):1281-8. Clin Cancer Res. 1999. PMID: 10389910

4

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.

Hoffmann TK, Nakano K, Elder EM, Dworacki G, Finkelstein SD, Appella E, Whiteside TL, DeLeo AB. Hoffmann TK, et al. Among authors: appella e. J Immunol. 2000 Nov 15;165(10):5938-44. doi: 10.4049/jimmunol.165.10.5938. J Immunol. 2000. PMID: 11067956

5

The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.

Ito D, Albers A, Zhao YX, Visus C, Appella E, Whiteside TL, DeLeo AB. Ito D, et al. Among authors: appella e. J Immunol. 2006 Nov 15;177(10):6795-803. doi: 10.4049/jimmunol.177.10.6795. J Immunol. 2006. PMID: 17082593

6

The p53 Saga: Early Steps in the Development of Tumor Immunotherapy.

DeLeo AB, Appella E. DeLeo AB, et al. Among authors: appella e. J Immunol. 2020 May 1;204(9):2321-2328. doi: 10.4049/jimmunol.1901343. J Immunol. 2020. PMID: 32312843 Free PMC article. Review.

7

Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.

Hoffmann TK, Donnenberg AD, Finkelstein SD, Donnenberg VS, Friebe-Hoffmann U, Myers EN, Appella E, DeLeo AB, Whiteside TL. Hoffmann TK, et al. Among authors: appella e. Cancer Res. 2002 Jun 15;62(12):3521-9. Cancer Res. 2002. PMID: 12067999

8

P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells.

Chikamatsu K, Albers A, Stanson J, Kwok WW, Appella E, Whiteside TL, DeLeo AB. Chikamatsu K, et al. Among authors: appella e. Cancer Res. 2003 Jul 1;63(13):3675-81. Cancer Res. 2003. PMID: 12839958

9

Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.

Fassanito MA, Loftus D, De Leo RM, Law LW, Appella E, De Leo AB. Fassanito MA, et al. Among authors: appella e. Cancer Res. 1994 Aug 15;54(16):4424-9. Cancer Res. 1994. PMID: 7519121

10

Analysis of MHC-specific peptide motifs. Applications in immunotherapy.

Loftus DJ, Kubo RT, Sakaguchi K, Celis E, Sette A, Appella E. Loftus DJ, et al. Among authors: appella e. Adv Exp Med Biol. 1995;383:201-10. doi: 10.1007/978-1-4615-1891-4_21. Adv Exp Med Biol. 1995. PMID: 8644503 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters